EpiBone, Inc. — Form D
EpiBone, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-24. The offering totals $4.3M, of which $4.3M was reported sold. Industry: Other.
Offering
- Filed: 2025-10-24
- Form: D
- Accession: 0001798436-25-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $4.3M
- Amount sold: $4.3M
- Remaining: $13K
- Investors: 131
- Date of first sale: 2025-09-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-562009
Issuer
- Name: EpiBone, Inc.
- CIK: 0001798436
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 521 5TH AVE, 17TH FLOOR, NEW YORK, NY, 10175
- Phone: 212-653-8828
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Sarindr Bhumiratana | Director | New York, NY |
| Robert Langer | Director | Pittsburgh, PA |
| Nina Tandon | Director | New York, NY |
| Gordana Vunjak-Novakovic | Director | New York, NY |
| David Zhu | Director | San DIego, CA |
| Sarindr Bhumiratana | Executive Officer | New York, NY |
| Nina Tandon | Executive Officer | New York, NY |
| Nina Tandon | Promoter | New York, NY |
| Elma Hawkins | Director | Brooklyn, NY |
Other filings by this issuer (3)
More